Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, announced that it has received CE Mark approval for its 021 Contour Neurovascular System™, compatible with smaller commercially available 021 microcatheters for the treatment of saccular intracranial aneurysms.
April 29, 2020
· 2 min read